Ways Forward for Tolerance-Inducing Cellular Therapies- an AFACTT Perspective

Ways Forward for Tolerance-Inducing Cellular Therapies- an AFACTT Perspective

Clinical studies with cellular therapies using tolerance-inducing cells, such as tolerogenic antigen-presenting cells (tolAPC) and regulatory T cells (Treg) for the prevention of transplant rejection and the treatment of autoimmune diseases have been expanding the last decade. In this perspective, w...

Full description

Bibliographic Details
Main Authors: Anja ten Brinke, Marc Martinez-Llordella, Nathalie Cools, Catharien M. U. Hilkens, S. Marieke van Ham, Birgit Sawitzki, Edward K. Geissler, Giovanna Lombardi, Piotr Trzonkowski, Eva Martinez-Caceres
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-02-01
Series:Frontiers in Immunology
Subjects:
tolerance
dendritic cells
regulatory T cells
autoimmunity
transplantation
cell therapy
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2019.00181/full

Internet

https://www.frontiersin.org/article/10.3389/fimmu.2019.00181/full

Similar Items